Dual Trigger, Urinary HCG or Recombinant HCG, Which is the Best !?

• Conditions: IVF

• Registration Number: NCT04265495
• Lead Sponsor: Al Baraka Fertility Hospital

Brief Summary

a comparative study among dual trigger, urinary HCG and recombinant HCG regarding the outcome of ICSI- antagonist cycles

Detailed Description

a comparative study among dual trigger, urinary HCG and recombinant HCG regarding the outcome (oocyte quality, fertilization rate, implantation rate, clinical pregnancy rate as well as the incidence of OHSS) in ICSI- antagonist cycles

Study Timeline

• Study Start: 2020-02-09
• Study First Submitted: 2020-02-09
• Study First Submitted QC: 2020-02-09
• Study First Posted: 2020-02-11
• Status Verified: 2021-09
• Last Update Submitted: 2021-09-27
• Last Update Posted: 2021-09-28
• Primary Completion: 2021-11-30
• Study Completion: 2021-12-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 600

Inclusion Criteria

• patients <40 years of age who underwent IVF/ICSI cycles using a GnRH antagonist protocol

Exclusion Criteria

• age: > 40 years
• BMI > 30 ,
• long agonist protocol
• were chromosomal and genetic disorders, abnormal ultrasonogram of the uterine cavity

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
clinical pregnancy rate,	4 WEEKS
implantation rate,	2 WEEKS
incidence of OHSS.	1 WEEK

Trial Locations

Locations (1)

Al-BARAKA FERTILITY HOSPITAL; 🇧🇭 Manama, Adliya, Bahrain